FIELD: chemical and pharmaceutical industry, medicine. SUBSTANCE: ointment has the following components, wt.-%: Aralia mandschurica (Lat.) 0.9-1.0; agrimony tomentose 0.9-1.1; bur-marigold 0.95-1.1; celandine major 0.9-1.15; toadflax flowers 0.4-0.6; Ahnfeltia 1.0-1.1; gum arabic 0.4-0.6; glucomannane mucus 0.4-0.6; crab chitin 0.9-2.0; birch tar 0.5-0.6; white bark fir essential oil 0.4-0.5; white bark fir distilled water 0.4-0.6, and medicinal lubricant grease - the rest. EFFECT: enhanced effectiveness of clinical recovery.
| Title | Year | Author | Number |
|---|---|---|---|
| OINTMENT FOR TREATMENT OF PATIENTS WITH PSORIASIS | 2000 |
|
RU2171682C1 |
| "ANTIPSORIAZ" CREAM | 2004 |
|
RU2246935C1 |
| THERAPEUTIC CREAM | 2006 |
|
RU2307646C1 |
| ANTI-INFLAMMATORY OINTMENT | 2004 |
|
RU2280458C1 |
| AGENT FOR THE TREATMENT OF PSORIASIS AND METHOD FOR ITS PRODUCTION | 2021 |
|
RU2776175C1 |
| OINTMENT FOR TREATING PSORIASIS (VERSIONS) | 2018 |
|
RU2705162C1 |
| METHOD OF PSORIASIS TREATMENT | 1995 |
|
RU2077319C1 |
| METHOD OF TREATING PSORIASIS | 2008 |
|
RU2382638C1 |
| METHOD FOR TREATING SKIN DISEASES | 2003 |
|
RU2245717C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH PSORIASIS (VARIANTS) AND METHOD OF ITS TREATMENT | 2000 |
|
RU2171683C1 |
